Cardinal Health reaffirms FY2027 non-GAAP EPS growth outlook of 13%-15%

PUBT · 1d ago
Cardinal Health reaffirms FY2027 non-GAAP EPS growth outlook of 13%-15%
  • Cardinal Health reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13% to 15%, implying $12.40 to $12.60.
  • Long-term non-GAAP EPS growth outlook maintained at 12% to 14%.
  • Growth assumptions use adjusted fiscal 2026 results, excluding the fiscal 2026 benefit from an IEEPA tariff refund.
  • Guidance reaffirmation coincided with a binding letter of intent to extend CVS pharmaceutical distribution services through June 30, 2032.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardinal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL61718) on October 01, 2026, and is solely responsible for the information contained therein.